NASDAQ

Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

367 Thanks from members

Scinai Immunotherapeutics Ltd. (SCNI) exhibits a high retail sentiment score alongside intense downward stock performance, a recent $2.61 million private placement, ongoing NASDAQ minimum bid price compliance challenges, and a pending 1-for-10 ADS ratio change.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →